Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Tenaya Therapeutics Inc’s stock clocked out at $1.08, down -2.70% from its previous closing price of $1.11. In other words, the price has decreased by -$2.70 from its previous closing price. On the day, 1.33 million shares were traded.
Ratios:
To gain a deeper understanding of TNYA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.27 and its Current Ratio is at 5.27. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.10.
On November 30, 2023, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.
On June 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.H.C. Wainwright initiated its Buy rating on June 15, 2022, with a $25 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 18 ’24 when Saito Chihiro sold 2,258 shares for $2.12 per share. The transaction valued at 4,787 led to the insider holds 60,983 shares of the business.
Saito Chihiro sold 2,363 shares of TNYA for $6,840 on Aug 16 ’24. The SVP, Accounting and Fin. Ops. now owns 63,241 shares after completing the transaction at $2.89 per share. On Aug 16 ’24, another insider, Tingley Whittemore, who serves as the Chief Medical Officer of the company, sold 7,428 shares for $2.89 each. As a result, the insider received 21,500 and left with 107,106 shares of the company.
Stock Price History:
Over the past 52 weeks, TNYA has reached a high of $7.01, while it has fallen to a 52-week low of $0.86. The 50-Day Moving Average of the stock is -25.66%, while the 200-Day Moving Average is calculated to be -57.54%.
Shares Statistics:
A total of 79.22M shares are outstanding, with a floating share count of 65.32M. Insiders hold about 17.55% of the company’s shares, while institutions hold 41.54% stake in the company.
